The year in molecular imaging.
Molecular imaging aims to enable personalized medicine via imaging-specific molecular and cellular targets that are relevant to the diagnosis and treatment of disease. By providing in vivo readouts of biological detail, molecular imaging complements traditional anatomical imaging modalities to allow: 1) visualization of important disease-modulating molecules and cells in vivo; 2) serial investigations to image evolutionary changes in disease attributes; and 3) evaluation of the in vivo molecular effects of biotherapeutics. The added information garnered by molecular imaging can improve risk assessment and prognosticative studies, this is of particular benefit in the management of cardiovascular disease (CVD).
Cardiology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Eric A
EA
Osborn
Farouc A
FA
Jaffer
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy; D006334:Heart Function Tests / Q000379:methods; D006801:Humans; D057054:Molecular Imaging / Q000379:methods; D057285:Precision Medicine; D011237:Predictive Value of Tests; D011379:Prognosis
D015415:Biomarkers